These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 17441890)
41. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease. Oktem M; Ozcimen EE; Uckuyu A; Esinler I; Pamuk B; Bayraktar N; Kulaksizoglu S; Zeyneloglu HB Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599 [TBL] [Abstract][Full Text] [Related]
42. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750 [TBL] [Abstract][Full Text] [Related]
43. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715 [TBL] [Abstract][Full Text] [Related]
44. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of hand functions in women with polycystic ovary syndrome. Soyupek F; Guney M; Eris S; Cerci S; Yildiz S; Mungan T Gynecol Endocrinol; 2008 Oct; 24(10):571-5. PubMed ID: 19012100 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea. Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292 [TBL] [Abstract][Full Text] [Related]
47. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710 [TBL] [Abstract][Full Text] [Related]
48. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412 [TBL] [Abstract][Full Text] [Related]
49. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172 [TBL] [Abstract][Full Text] [Related]
50. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780 [TBL] [Abstract][Full Text] [Related]
51. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome. Ferk P; Teran N; Gersak K Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294 [TBL] [Abstract][Full Text] [Related]
52. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome]. Hu WH; Qiao J; Li R; Wang LN Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783 [TBL] [Abstract][Full Text] [Related]
53. A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity? Alanbay I; Ercan CM; Sakinci M; Coksuer H; Ozturk M; Tapan S Arch Gynecol Obstet; 2012 Oct; 286(4):1065-71. PubMed ID: 22718099 [TBL] [Abstract][Full Text] [Related]
54. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
55. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Shi Y; Gao X; Sun X; Zhang P; Chen Z Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857 [TBL] [Abstract][Full Text] [Related]
56. The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS). Wassell J; Michail M; Soliman N; Wardle PG Clin Lab; 2011; 57(1-2):95-8. PubMed ID: 21391472 [TBL] [Abstract][Full Text] [Related]
57. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993 [TBL] [Abstract][Full Text] [Related]
58. The Value of Prostate-Specific Antigen in Diagnosis of Polycystic Ovarian Syndrome in Adolescent Girls. Tokmak A; Bodur S; Erkilinc S; Ozel S; Engin-Ustun Y J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):263-269. PubMed ID: 29162532 [TBL] [Abstract][Full Text] [Related]
59. Paraoxonase levels in women with polycystic ovary syndrome. Fenkci IV; Serteser M; Fenkci S; Kose S J Reprod Med; 2007 Oct; 52(10):879-83. PubMed ID: 17977159 [TBL] [Abstract][Full Text] [Related]
60. Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women. Kocak M; Tarcan A; Beydilli G; Koç S; Haberal A Gynecol Endocrinol; 2004 Apr; 18(4):179-85. PubMed ID: 15293888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]